Cytochrome P450 as possible link between Mallory-Denk body formation in DDC-intoxicated mouse liver and human

Cornelia Stumptner1, Karoline Fechter1, Kurt Zatloukal1

  • 1Diagnostic and Research Institute of Pathology, Center of Molecular Biomedicine, Medical University of Graz, Neue Stiftingtalstrasse 6, 8010, Graz, Austria.

Insights

Mallory-Denk bodies (MDBs) in liver disease are linked to cellular stress. Researchers found that cytochrome P450 (CYP) enzymes, specifically CYP2A5 in mice and CYP2E1/CYP2A6 in humans, contribute to MDB formation through reactive oxygen species (ROS) production.

Area of Science:

  • Hepatology
  • Biochemistry
  • Cellular Biology

Background:

  • Mallory-Denk bodies (MDBs) are protein inclusions found in various chronic liver diseases, including alcohol-related (ASH) and metabolic dysfunction-associated steatohepatitis (MASH).
  • MDBs are associated with chronic cellular stress and can be experimentally induced in mice using 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC).

Purpose of the Study:

  • To investigate the role of cytochrome P450 (CYP) enzymes and oxidative stress in the formation of MDBs.
  • To explore the relationship between CYP expression, enzyme activity, and cellular stress responses during MDB development.

Main Methods:

  • Mice were subjected to chronic DDC intoxication, followed by recovery and re-intoxication.
  • Analysis included gene expression (mRNA) of CYP2A5, heme oxygenase-1 (Hmox-1), and p62, as well as CYP protein levels and coumarin 7-hydroxylase (COH) activity.
  • In vitro experiments assessed reactive oxygen species (ROS) production by CYPs and inhibition by bilirubin.

Main Results:

  • DDC treatment significantly elevated mRNA levels of CYP2A5, Hmox-1, and p62.
  • CYP2A5 protein expression correlated with MDB presence, and CYP2A5 activity (COH) increased with MDB formation.
  • Bilirubin was identified as an inhibitor of CYP2A5-induced ROS production. Human steatohepatitis-associated CYPs (CYP2E1, CYP2A6) showed similar ROS production and bilirubin inhibition.

Conclusions:

  • Overexpression of ROS-producing CYP2A5 in mice and CYP2E1/CYP2A6 in humans may represent a common pathogenic mechanism in MDB formation.
  • These findings highlight the role of specific CYP enzymes and oxidative stress in the pathogenesis of MDB-associated liver disorders.

Related Concept Videos